Press release
Rising Prevalence of Viral Diseases Drives Growth in Biomanufacturing Viral Detection and Quantification Market
Biomanufacturing Viral Detection Quantification Market
Biomanufacturing viral detection and quantification tools, such as diagnostic kits and assays, allow healthcare providers to identify viruses accurately and quickly in patient samples. Early detection facilitates timely treatment and containment, helping to curb the spread of infections and improve patient outcomes. These tools also play a crucial role in epidemiological monitoring, enabling health authorities to track outbreaks, identify disease patterns, and assess the effectiveness of control measures. The global response to health emergencies, such as the COVID-19 pandemic, has highlighted the importance of reliable viral detection technologies. Governments, healthcare systems, and businesses are increasingly investing in biomanufacturing infrastructure to enhance preparedness for future outbreaks, driving demand for scalable viral detection solutions.
Get Free Sample Report and Related Graphs & Charts @https://www.emergenresearch.com/request-sample/3612
Market Drivers: Stricter Regulations on Viral Safety
The market for biomanufacturing viral detection and quantification is also being driven by stricter regulatory requirements for viral safety. Viral clearance studies are a crucial step in biologics production, ensuring product safety before regulatory approval. Regulatory agencies emphasize the need for rigorous testing and data validation to support applications for investigational new drugs (INDs) and biologics license applications (BLAs). Over the past few decades, guidelines have been established to reduce the risk of viral transmission in pharmaceutical products. In 2022, the International Council for Harmonisation (ICH) introduced new guidelines for testing and evaluating the viral safety of biotechnology products derived from human or animal cell lines. These guidelines provide biopharmaceutical manufacturers with detailed information on required tests and safety data for marketing applications, ensuring stringent virus clearance measures are in place.
Market Challenges: High Research and Development Costs
Despite strong market growth, high research and development (R&D) costs present a significant challenge. Developing and validating new viral detection methods involves extensive investment, which can strain the financial resources of smaller companies and startups. Limited funding may hinder innovation and restrict competition, slowing the introduction of new and advanced detection technologies. Additionally, lengthy and costly R&D processes can delay the availability of critical viral detection solutions during outbreaks. Ensuring accuracy and reliability in complex sample matrices and rapidly evolving viruses further adds to these costs. The production of high-quality reagents and materials for viral detection requires significant investment in research, manufacturing, and quality control, posing additional financial barriers for market players.
Market Segmentation: Consumables Leading, Instruments Growing Rapidly
The biomanufacturing viral detection and quantification market is segmented into consumables, instruments, and services. In 2023, consumables emerged as the leading segment, driven by the widespread use of testing kits, reagents, and accessories essential for viral detection procedures. Consumables are used repeatedly throughout the testing process, ensuring efficient and accurate viral analysis.
The instruments segment is experiencing the fastest growth, fueled by the rising demand for advanced viral detection technologies. High-performance tools such as Polymerase Chain Reaction (PCR) devices, next-generation sequencing systems, and other high-throughput technologies are becoming increasingly important for ensuring product safety and regulatory compliance in biomanufacturing. The need for rapid and precise results is driving investments in cutting-edge diagnostic instruments, further accelerating market expansion.
As viral diseases continue to pose significant public health challenges, the demand for effective detection and quantification tools is set to rise. The biomanufacturing sector is expected to witness continued investment in research and technology to enhance diagnostic capabilities, improve outbreak preparedness, and ensure compliance with stringent safety regulations. Industry stakeholders, including healthcare providers, governments, and biotech companies, are actively working to develop innovative solutions that can respond swiftly to emerging viral threats and safeguard global health.
Request A Discount On The Report @https://www.emergenresearch.com/request-discount/3612
Biomanufacturing Viral Detection Quantification Top Companies and Competitive Landscape
The Biomanufacturing Viral Detection Quantification Industry is essential for the safety and efficacy of biopharmaceutical products. This industry develops methods and technologies to detect and quantify viral contaminants in biological materials. Demand for biologics and advanced therapies has been on the increase, making the need for reliable viral detection critical.
The key players in the market are Danaher Corporation, Merck KGaA, New England Biolabs, and TAKARA HOLDINGS INC., which have been accredited for their innovative solutions and the quality assurance measures they use. As regulatory demands increase the industry is also expected to grow with the developments in the detection technologies and increased attention towards ensuring safety in bioprocessing.
In September 2021, Thermo Fisher Scientific signed a definitive agreement with Becton, Dickinson, and Company (BDX) to acquire their Advanced Bioprocessing division. This BD company generated over $100 million in annual revenue and was acquired by Thermo Fisher's Life Sciences Solutions Segment on October 16, 2021.
Some of the key companies in the global Biomanufacturing Viral Detection Quantification market include:
Danaher Corporation
Merck KGaA
New England Biolabs
TAKARA HOLDINGS INC.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Sartorius AG
Charles River Laboratories
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Promega Corporation
QIAGEN N.V.
Genscript Biotech Corporation
Norgen Biotek Corp.
Request Customization Of The Report @https://www.emergenresearch.com/request-for-customization/3612
Biomanufacturing Viral Detection Quantification Latest Industry Updates
In March 2023, Danaher Corporation, a global leader in research and technology, and the University of Pennsylvania (Penn) collaborated to explore new cell therapy approaches. The multiyear partnership's goals are to develop new technologies, decrease production bottlenecks, and give patients next-generation engineered cell products with more consistent clinical results.
In June 2023. Merck, one of the world's premier scientific and technology corporations, is expanding manufacturing capacity for highly purified reagents at its Nantong facility, which is a significant transportation hub in China and serves the Yangtze River Delta region. The €70 million investment will allow for the large-scale manufacturing of high-purity reagents for quality control and testing to fulfil the needs of biopharma clients, with an annual output increase of several thousand tonnes. Today. Merck struck an agreement to assist the expansion of the Nantong plant with the Nantong economic and technology development area (NETDA).
Biomanufacturing Viral Detection Quantification Market Segmentation Analysis
Offering Type Outlook (Revenue, USD Million; 2020-2033)
Consumables
Instruments
Services
Technology Outlook (Revenue, USD Million; 2020-2033)
PCR
ELISA
Flow Cytometry
Plaque Assay
Others
Application Outlook (Revenue, USD Million; 2020-2033)
Blood and Blood Products Manufacturing
Vaccines and Therapeutics Manufacturing
Cellular and Gene Therapy Products Manu
Stem Cell Products Manufacturing
Tissue and Tissue Products Manufacturing
End User Outlook (Revenue, USD Million; 2020-2033)
Life Science Companies
Testing Laboratories
CROs and CDMOs
Regional Outlook (Revenue, USD Million; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Click here to Buy Now @https://www.emergenresearch.com/select-license/3612
Read Similar Reports By Emergen Research:
Biomanufacturing Viral Detection Quantification Market Size @ https://www.emergenresearch.com/industry-report/biomanufacturing-viral-detection-quantification-market/market-size
Biomanufacturing Viral Detection Quantification Market Share @ https://www.emergenresearch.com/industry-report/biomanufacturing-viral-detection-quantification-market/market-share
Biomanufacturing Viral Detection Quantification Market Trends @ https://www.emergenresearch.com/industry-report/biomanufacturing-viral-detection-quantification-market/market-trends
Biomanufacturing Viral Detection Quantification Regional Market Demand @ https://www.emergenresearch.com/industry-report/biomanufacturing-viral-detection-quantification-market/regional-market-demand
Biomanufacturing Viral Detection Quantification Market Analysis @ https://www.emergenresearch.com/industry-report/biomanufacturing-viral-detection-quantification-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence of Viral Diseases Drives Growth in Biomanufacturing Viral Detection and Quantification Market here
News-ID: 3854791 • Views: …
More Releases from Emergen Research
Digital Neuro Biomarkers Market Growth Research Report 2024-2030 | 250 Pages
The digital neuro biomarkers market is expected to grow from an estimated USD 0.8 billion in 2024 to USD 6.4 billion in 2033 at a CAGR of 26.0%.
The digital neuro biomarkers market is experiencing rapid growth due to the increasing prevalence of neurological disorders and advancements in digital health technologies. Digital neuro biomarkers are objective measures collected through digital devices such as wearables, smartphones, and biosensors to assess brain function…
Dermatology Imaging Market Growth Research Report 2024-2030 | 250 Pages
The dermatology imaging market is expected to grow from an estimated USD 2.6 billion in 2024 to USD 8.1 billion in 2033, at a CAGR of 13.5%.
The dermatology imaging market is experiencing significant growth due to the increasing prevalence of skin disorders, advancements in imaging technologies, and growing awareness about early skin disease detection. Dermatology imaging involves the use of specialized devices such as dermatoscopes, confocal microscopes, optical coherence tomography…
Dental Bone Void Filler Market Growth Research Report 2024-2030 | 250 Pages
The dental bone void filler market is expected to grow from an estimated USD 121.6 million in 2024 to USD 205.4 million in 2033 at a CAGR of 6.0%.
The dental bone void filler market is experiencing significant growth due to the increasing prevalence of dental disorders, rising awareness about oral health, and advancements in regenerative dentistry. Dental bone void fillers are used in various dental procedures, including bone grafting, implant…
Dairy Products Packaging Market Growth Research Report 2024-2030 | 250 Pages
The Dairy Products Packaging market is expected to grow from an estimated USD 28.5 billion in 2024 to USD 42.7 billion in 2033, at a CAGR of 4.60%.
The dairy products packaging market is witnessing steady growth due to the rising global demand for milk, cheese, yogurt, butter, and other dairy-based products. Packaging plays a crucial role in preserving the freshness, quality, and shelf life of dairy items while ensuring convenience…
More Releases for Viral
Viral Inactivation Market Growing Demand of Kits and Reagents Viral Inactivation …
According to Precision Business Insights (PBI), the latest report, the Viral Inactivation market is expected to be worth USD 2.1 billion in 2022, growing at a 12.8% CAGR from 2022 to 2028. The primary driver of the expansion of the global Viral Inactivation market are speedy growth in pharmaceutical and biotechnology industries and strong inclination of R&D investments in life sciences industry.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/viral-inactivation-market/
Kits &…
Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry …
Anti-viral drug therapy market comprises of sales of branded & generic anti-viral drugs and related services by entities that manufacture the branded or generic anti-viral drugs for treating microbial infections. Anti-viral drug therapy industry includes several establishments that manufacture anti-viral drugs, which are used to treat diseases caused by viral infections. Examples of antiviral drugs include cidofovir, amantadine, zanamivir, idoxuridine, famiciclovir, tenofovir, adefovir and ribavirin.
According to study, “Anti-Viral Drug Therapy…
Viral Antigens Market to Reap Excessive Revenues by 2028(Based on product type, …
Antigens are commonly referred to as substances that are capable of triggering an immune response in a host by activating the lymphocytes or initiating antibody production against infections. Depending upon the fact that they either enter the human body or originate within the body, viral antigens are classified as foreign or self-antigens respectively. Among these, self-antigens comprise mutated or overexpressed proteins. However, foreign antigens are likely to include bacteria, parasites,…
Viral Vector and Plasmid DNA Manufacturing Market - Increase In Awareness Regard …
The Viral Vector and Plasmid DNA Manufacturing Market is expected to reach $ 1,090 million in 2023, growing at an annual average rate of 22.6% from 2017 to 2023. North America was the largest contributor to the viral vector and plasmid DNA markets in 2016. However, the Asia Pacific region is expected to have the highest growth rate during the forecast period.
Gene therapy has included tools such as viral vectors…
Viral Vaccines Market : Challenges and Opportunities Against Viral Diseases
Vaccines are biotic compositions. They are basically formulated from living beings that increase the resistance against a specific illness. Vaccinations that help in avoiding the occurrence of specific diseases are known as prophylactic vaccines and in other instance, the vaccines that are helpful in treating the disease are called therapeutic vaccines. A vaccine is generally produced by using a weakened or murdered type of the sickness causing microorganism. The agent…
Global Viral Molecular Diagnostics Market
The Viral Molecular Diagnostics Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. Viral molecular diagnostic helps in…
